ATE439439T1 - Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung - Google Patents

Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung

Info

Publication number: ATE439439T1
Authority: AT; Austria
Prior art keywords: disulfide; production; cross; glycoprotein hormones; linked glycoprotein
Prior art date: 1997-06-25

Application number

AT06015992T

Other languages

English (en)

Inventor

William R Moyle

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-25

Filing date

1998-06-25

Publication date

2009-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21967404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE439439(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-25 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2009-08-15 Application granted granted Critical

2009-08-15 Publication of ATE439439T1 publication Critical patent/ATE439439T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Reproductive Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Gynecology & Obstetrics (AREA)
Wood Science & Technology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT06015992T 1997-06-25 1998-06-25 Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung ATE439439T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5078497P	1997-06-25	1997-06-25

Publications (1)

Publication Number	Publication Date
ATE439439T1 true ATE439439T1 (de)	2009-08-15

Family

ID=21967404

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT98930477T ATE335000T1 (de)	1997-06-25	1998-06-25	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
AT06015992T ATE439439T1 (de)	1997-06-25	1998-06-25	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT98930477T ATE335000T1 (de)	1997-06-25	1998-06-25	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung

Country Status (20)

Country	Link
US (1)	US8530190B1 (de)
EP (2)	EP1775346B1 (de)
JP (3)	JP3950484B2 (de)
KR (2)	KR100560279B1 (de)
CN (3)	CN100404551C (de)
AR (1)	AR013139A1 (de)
AT (2)	ATE335000T1 (de)
AU (1)	AU747179B2 (de)
BR (1)	BR9810478A (de)
CA (1)	CA2293731C (de)
CY (2)	CY1105763T1 (de)
DE (2)	DE69835433T2 (de)
DK (2)	DK0996629T3 (de)
ES (2)	ES2332931T3 (de)
HU (1)	HU227908B1 (de)
IL (2)	IL133686A0 (de)
PT (2)	PT1775346E (de)
SI (2)	SI0996629T1 (de)
WO (1)	WO1998058957A2 (de)
ZA (1)	ZA985545B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716428B1 (en) *	1999-10-06	2004-04-06	The Ohio State University Research Foundation	Antigenic modification of polypeptides
PT1261622E (pt) *	2000-02-22	2007-04-30	Applied Research Systems	Lh purificada
WO2002030978A1 (en) *	2000-10-06	2002-04-18	Regeneron Pharmaceuticals, Inc.	Polypeptides, methods of making, and uses thereof
CA2466595A1 (en) *	2001-11-08	2003-05-15	William R. Moyle	Protein knobs
KR20080043301A (ko)	2005-09-14	2008-05-16	아레스 트레이딩 에스.에이.	폴록사머의 정량 방법
RS51792B (sr) *	2006-01-17	2011-12-31	Merck Serono Sa.	Novi fsh sa glikozilacijom varijante d3n
CN101250531B (zh) *	2006-11-27	2013-04-24	株式会社Lg生命科学	一核苷酸序列、包含该序列的表达载体、该载体转化的动物细胞及利用该细胞生产人fsh的方法
EP2412385A1 (de)	2008-02-08	2012-02-01	BioGeneriX AG	Flüssige Formulierung von FSH
CN101347613B (zh) *	2008-09-17	2011-10-26	上海天伟生物制药有限公司	几乎不含亚基的糖蛋白的组合物及其制备方法
CA2747825A1 (en) *	2009-01-22	2010-07-29	Novo Nordisk Health Care Ag	Stable growth hormone compounds
KR101761168B1 (ko)	2009-04-01	2017-07-25	바이오제너릭스 게엠베하	재조합 ｆｓｈ 정제 방법
TWI532495B (zh)	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2325194A1 (de)	2009-11-24	2011-05-25	Glycotope GmbH	Verfahren zur Reinigung von Glykoproteinen
RU2012134974A (ru)	2010-01-22	2014-02-27	Ново Нордиск Хелс Кеа Аг	Стабилизированное соединение гормона роста
RU2605627C2 (ru)	2010-01-22	2016-12-27	Ново Нордиск Хелс Кеа Аг	Гормоны роста с пролонгированной эффективностью in vivo
WO2012131306A1 (en)	2011-03-31	2012-10-04	Ferring B.V.	Pharmaceutical preparation
EP3572515B1 (de) *	2012-07-30	2021-07-21	Trophogen Inc.	Langwirkende glykoproteinhormon-superagonisten
EP2981282B1 (de)	2013-04-05	2020-11-04	Novo Nordisk Health Care AG	Wachstumshormonverbindungsformulierung
JP2023544722A (ja) *	2020-09-30	2023-10-25	ザユニバーシティオブノースカロライナアットチャペルヒル	操作された安定な乳酸オキシドレダクターゼ、その組成物、デバイス、キットおよび使用
WO2022150878A1 (en) *	2021-01-13	2022-07-21	University Of Newcastle	Compositions and methods of using targeting peptides and nanopharmaceuticals for the sterilization of cats and dogs
AU2023378481A1 (en) *	2022-11-10	2025-06-19	Kanglitai Biomedical (Qingdao) Co., Ltd.	Site-specific pegylated heteromeric protein or polypeptide, and preparation method therefor and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5079230A (en) *	1988-09-12	1992-01-07	Pitman-Moore, Inc.	Stable bioactive somatotropins
US5691455A (en) *	1995-10-24	1997-11-25	Akzo Nobel N.V.	Gonadotropins with non-native disulfide bridges
US20090209453A1 (en) *	2005-04-13	2009-08-20	University Of Medicine And Dentistry Of New Jersey	Glycoprotein Hormone Analogs

1998
- 1998-06-25 BR BR9810478-0A patent/BR9810478A/pt active Search and Examination
- 1998-06-25 CN CNB2003101028468A patent/CN100404551C/zh not_active Expired - Fee Related
- 1998-06-25 SI SI9830857T patent/SI0996629T1/sl unknown
- 1998-06-25 ES ES06015992T patent/ES2332931T3/es not_active Expired - Lifetime
- 1998-06-25 KR KR1019997011858A patent/KR100560279B1/ko not_active Expired - Fee Related
- 1998-06-25 PT PT06015992T patent/PT1775346E/pt unknown
- 1998-06-25 DE DE69835433T patent/DE69835433T2/de not_active Expired - Lifetime
- 1998-06-25 CA CA002293731A patent/CA2293731C/en not_active Expired - Fee Related
- 1998-06-25 AT AT98930477T patent/ATE335000T1/de active
- 1998-06-25 SI SI9830920T patent/SI1775346T1/sl unknown
- 1998-06-25 AU AU79861/98A patent/AU747179B2/en not_active Ceased
- 1998-06-25 EP EP06015992A patent/EP1775346B1/de not_active Expired - Lifetime
- 1998-06-25 ZA ZA985545A patent/ZA985545B/xx unknown
- 1998-06-25 WO PCT/US1998/013070 patent/WO1998058957A2/en not_active Ceased
- 1998-06-25 US US09/104,400 patent/US8530190B1/en not_active Expired - Fee Related
- 1998-06-25 IL IL13368698A patent/IL133686A0/xx active IP Right Grant
- 1998-06-25 HU HU0100681A patent/HU227908B1/hu not_active IP Right Cessation
- 1998-06-25 DK DK98930477T patent/DK0996629T3/da active
- 1998-06-25 JP JP50500099A patent/JP3950484B2/ja not_active Expired - Fee Related
- 1998-06-25 CN CNB988078112A patent/CN1197968C/zh not_active Expired - Fee Related
- 1998-06-25 CN CNB2003101028449A patent/CN1302010C/zh not_active Expired - Fee Related
- 1998-06-25 EP EP98930477A patent/EP0996629B1/de not_active Expired - Lifetime
- 1998-06-25 PT PT98930477T patent/PT996629E/pt unknown
- 1998-06-25 KR KR1020047004407A patent/KR100706469B1/ko not_active Expired - Fee Related
- 1998-06-25 DK DK06015992T patent/DK1775346T3/da active
- 1998-06-25 AT AT06015992T patent/ATE439439T1/de active
- 1998-06-25 ES ES98930477T patent/ES2268781T3/es not_active Expired - Lifetime
- 1998-06-25 DE DE69841063T patent/DE69841063D1/de not_active Expired - Lifetime
- 1998-06-26 AR ARP980103091A patent/AR013139A1/es active IP Right Grant
1999
- 1999-12-23 IL IL133686A patent/IL133686A/en not_active IP Right Cessation
2004
- 2004-10-27 JP JP2004312947A patent/JP4279768B2/ja not_active Expired - Lifetime
2006
- 2006-08-17 JP JP2006222581A patent/JP4278668B2/ja not_active Expired - Lifetime
- 2006-11-01 CY CY20061101598T patent/CY1105763T1/el unknown
2009
- 2009-09-24 CY CY20091100994T patent/CY1109439T1/el unknown

Also Published As

Publication number	Publication date
DE69841063D1 (de)	2009-09-24
IL133686A0 (en)	2001-04-30
IL133686A (en)	2007-07-24
KR100560279B1 (ko)	2006-03-10
ZA985545B (en)	1999-04-01
HK1033149A1 (en)	2001-08-17
KR20020006720A (ko)	2002-01-26
DK1775346T3 (da)	2009-09-28
CA2293731C (en)	2010-01-12
SI1775346T1 (sl)	2009-10-31
CN1548459A (zh)	2004-11-24
HUP0100681A1 (hu)	2001-06-28
JP2007016040A (ja)	2007-01-25
WO1998058957A2 (en)	1998-12-30
JP4279768B2 (ja)	2009-06-17
AR013139A1 (es)	2000-12-13
CN1302010C (zh)	2007-02-28
AU747179B2 (en)	2002-05-09
CY1109439T1 (el)	2014-08-13
KR20040039421A (ko)	2004-05-10
HUP0100681A3 (en)	2004-03-01
EP0996629A2 (de)	2000-05-03
HU227908B1 (en)	2012-05-29
US8530190B1 (en)	2013-09-10
SI0996629T1 (sl)	2006-12-31
ES2332931T3 (es)	2010-02-15
CA2293731A1 (en)	1998-12-30
DK0996629T3 (da)	2006-12-04
WO1998058957A9 (en)	1999-06-03
AU7986198A (en)	1999-01-04
WO1998058957A3 (en)	1999-04-22
PT996629E (pt)	2006-12-29
CN1548458A (zh)	2004-11-24
CN1269833A (zh)	2000-10-11
DE69835433D1 (de)	2006-09-14
EP1775346A1 (de)	2007-04-18
EP0996629B1 (de)	2006-08-02
JP2005162734A (ja)	2005-06-23
ATE335000T1 (de)	2006-08-15
PT1775346E (pt)	2009-08-25
JP3950484B2 (ja)	2007-08-01
CY1105763T1 (el)	2011-02-02
CN100404551C (zh)	2008-07-23
CN1197968C (zh)	2005-04-20
BR9810478A (pt)	2000-09-12
EP1775346B1 (de)	2009-08-12
JP2001521402A (ja)	2001-11-06
JP4278668B2 (ja)	2009-06-17
ES2268781T3 (es)	2007-03-16
KR100706469B1 (ko)	2007-04-10
DE69835433T2 (de)	2007-03-08

Legal Events

Date

Code

Title

Description

2010-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1775346

Country of ref document: EP

Publication	Publication Date	Title
DE69529026D1 (de)	2003-01-16	Trehalose, ihre Herstellung und ihre Verwendung
ATE239693T1 (de)	2003-05-15	3,3-diarylpropylamine , ihre verwendung und herstellung
ATE335000T1 (de)	2006-08-15	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
DE69627411D1 (de)	2003-05-22	Triazinderivate, ihre Herstellung und Verwendung
DE69812710D1 (de)	2003-04-30	Löslicher magnesiumhalogenidkomplex, herstellung und verwendung
ATE258549T1 (de)	2004-02-15	Oxazolidindion-derivate, ihre herstellung und verwendung
DE69817611D1 (de)	2003-10-02	2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
DE59709806D1 (de)	2003-05-15	Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
DE60038200D1 (de)	2008-04-17	ren Herstellung und Verwendung
ATA189691A (de)	1997-10-15	Hpth-peptide, ihre herstellung und verwendung
ATE286021T1 (de)	2005-01-15	Substituierte phenylderivate, ihre herstellung und verwendung
DE10084441T1 (de)	2002-03-21	Koalinton-Pigmente, ihre Herstellung und Verwendung
DE69625857D1 (de)	2003-02-27	Siliconderivate, ihre Herstellung und Verwendung
DE59703980D1 (de)	2001-08-16	Reaktivfarbstoffe, ihre Herstellung und Verwendung
DE59802590D1 (de)	2002-02-14	Cyclische Cedren-Acetale, ihre Herstellung und ihre Verwendung
DE59702018D1 (de)	2000-08-17	Azofarbstoffe, ihre Herstellung und Verwendung
DE59710272D1 (de)	2003-07-17	Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE69810521D1 (de)	2003-02-13	Abbeizzusammensetzungen, ihre Herstellung und Verwendung
DE59409541D1 (de)	2000-11-02	Bicyclen-derivate, ihre herstellung und verwendung
DE69521595D1 (de)	2001-08-09	Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE59802922D1 (de)	2002-03-14	3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
ATE268760T1 (de)	2004-06-15	Neue carbonsäurederivate, ihre herstellung und verwendung
DE69723463D1 (de)	2003-08-14	Cyclische organoselenderivate, ihre herstellung und verwendung
DE59703086D1 (de)	2001-04-12	Faserreaktive Farbstoffe, ihre Herstellung und Verwendung
DE69911243D1 (de)	2003-10-16	Benzofuranderivate, ihre herstellung und verwendung